Avantor Q3: Revenue decline deepens as management launches a turnaround plan

Transcript intelligence

What changed

Compared with the prior-quarter picture of flat Q2 revenue and a full-year organic-growth outlook of -2% to 0%, management’s Q3 analysis reports a 5% organic revenue decline and a revised 2025 organic-growth outlook of -3.5% to -2.5%. Management introduced the five-pillar Avantor Revival program. The supplied Q3 analysis also records a $785 million goodwill impairment on the lab distribution business and board authorization of a $500 million share repurchase program.

Guidance delta

Management lowered its 2025 organic revenue growth outlook to -3.5% to -2.5%, from the prior-quarter range of -2% to 0%.

Key takeaways

• Q3 organic revenue declined 5%, with the lab segment weaker than expected.
• Management lowered its full-year 2025 organic-growth outlook to -3.5% to -2.5%.
• Avantor Revival centers on go-to-market changes, manufacturing, portfolio focus, cost reduction and talent.
• The analysis notes a $785 million goodwill impairment on the lab distribution business and a newly authorized $500 million repurchase program.

Management priorities

• Execute the five-pillar Avantor Revival program across commercial operations, manufacturing, portfolio, cost and talent.
• Invest in manufacturing upgrades and supply-chain reliability.
• Rework brand architecture and expand e-commerce capabilities.
• Continue the cost transformation program, which targets $400 million in run-rate savings by 2027.